Received Dec 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
covid 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid 19) in a patient of an unknown age and gender who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: COVID-19 Vaccine (previous 6 doses.). Past adverse reactions to the above products included No adverse effect with COVID-19 Vaccine. On an unknown date, the patient received seventh dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. In September 2025, the patient experienced COVID-19 (covid 19). At the time of the report, COVID-19 (covid 19) outcome was unknown. No concomitant medication was reported. Patient had a recent COVID infection (3 months ago - third overall) and had 7 previous COVID vaccines. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported. Event causality was not provided.